Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial Dan Ziegler, Phillip A.
Excerpt from:
Alpha Lipoic Acid (ALA) for Diabetic Neuropathy
Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial Dan Ziegler, Phillip A.
Excerpt from:
Alpha Lipoic Acid (ALA) for Diabetic Neuropathy
Related posts: